Stay updated on Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial

Sign up to get notified when there's something new on the Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Site revision updated to v3.4.3, replacing the prior Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T17:55:24.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Footer now displays Revision: v3.4.2 and the older government funding/operating status notices (v3.4.1) have been removed.
    Difference
    0.4%
    Check dated 2026-02-11T02:21:06.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Notice about a lapse in government funding and the NIH Clinical Center's operating status added; site revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-03T23:04:34.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    UI and metadata updates include a glossary toggle, a new label 'Last Update Submitted that Met QC Criteria' for QC status, capitalization changes for 'No FEAR Act Data', and a new page revision indicator 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-27T20:01:57.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-20T14:38:43.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added new study locations: Fujian, Gansu, Heilongjiang, Henan, Shandong, Sichuan, Tianjin Municipality, Zhejiang (China) and Gyeonggi-do, Seoul Teugbyeolsi (South Korea). Updated revision tag from v3.3.2 to v3.3.3.
    Difference
    1%
    Check dated 2025-12-22T21:56:34.000Z thumbnail image

Stay in the know with updates to Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial page.